US 12,220,524 B2
Inhaler system
Xinyu Liu, Winchester, MA (US); Jenna-Leigh Meola, Cambridge, MA (US); Cody Goldberg, Cambridge, MA (US); Jinn Kim, Cambridge, MA (US); Sunil Kumar Mishra, Cambridge, MA (US); and Vered Ben-Anat, Cambridge, MA (US)
Assigned to Norton (Waterford) Limited, Waterford (IE)
Filed by Norton (Waterford) Limited, Waterford (IE)
Filed on Aug. 26, 2022, as Appl. No. 17/896,526.
Application 17/896,526 is a continuation of application No. 16/906,896, filed on Jun. 19, 2020, granted, now 11,464,923.
Prior Publication US 2022/0401667 A1, Dec. 22, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 15/00 (2006.01); A61B 5/00 (2006.01); A61B 5/087 (2006.01); A61M 11/02 (2006.01); G06F 21/60 (2013.01); G06K 7/14 (2006.01); G16H 20/13 (2018.01); G16H 40/67 (2018.01); H04L 9/40 (2022.01); A61M 11/00 (2006.01); A61M 16/00 (2006.01)
CPC A61M 15/0001 (2014.02) [A61B 5/0871 (2013.01); A61B 5/4833 (2013.01); A61B 5/7246 (2013.01); A61B 5/7435 (2013.01); A61M 11/02 (2013.01); G06F 21/602 (2013.01); G06K 7/1417 (2013.01); G16H 20/13 (2018.01); H04L 63/0428 (2013.01); A61M 11/00 (2013.01); A61M 15/0026 (2014.02); A61M 15/003 (2014.02); A61M 15/008 (2014.02); A61M 15/009 (2013.01); A61M 2016/0027 (2013.01); A61M 16/024 (2017.08); A61M 2202/064 (2013.01); A61M 2205/18 (2013.01); A61M 2205/27 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3358 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3375 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2205/6018 (2013.01); A61M 2205/6072 (2013.01); G16H 40/67 (2018.01)] 25 Claims
OG exemplary drawing
 
1. A system comprising:
a first inhaler configured to deliver a first medicament to a subject for a treatment of a respiratory disease of the subject, the first inhaler comprising:
a sensor for detecting inhalation of the first medicament performed by the subject;
a processor configured to determine a first airflow parameter relating to airflow during inhalation of the first medicament performed by the subject using the first inhaler, and encrypt first data based on the first airflow parameter; and
a transmitter configured to transmit the encrypted first data; and
a second inhaler configured to deliver a second medicament to the subject for the treatment of the respiratory disease, the second medicament being different from the first medicament, the second inhaler comprising:
a sensor for detecting inhalation of the second medicament performed by the subject;
a processor configured to determine a second airflow parameter relating to airflow during inhalation of the second medicament performed by the subject using the second inhaler, and encrypt second data based on the second airflow parameter; and
a transmitter configured to transmit the encrypted second data;
a non-transitory computer-readable storage medium residing on an external device, wherein the non-transitory computer-readable storage medium comprises computer-executable instructions that, when executed by a processor of the external device cause the processor of the external device to:
receive the first encrypted data and the second encrypted data;
distinguish between the first encrypted data and the second encrypted data to determine the first airflow parameter based on the distinguished first encrypted data and to determine the second airflow parameter based on the distinguished second encrypted data; and
display the first airflow parameter and the second airflow parameter simultaneously in a single graphical user interface (GUI) via a display device of the external device.